nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—MAOA—attention deficit hyperactivity disorder	0.41	0.512	CbGaD
Rizatriptan—HTR1B—attention deficit hyperactivity disorder	0.391	0.488	CbGaD
Rizatriptan—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.0104	0.222	CbGeAlD
Rizatriptan—HTR1F—forebrain—attention deficit hyperactivity disorder	0.00427	0.0911	CbGeAlD
Rizatriptan—HTR1F—nervous system—attention deficit hyperactivity disorder	0.00232	0.0494	CbGeAlD
Rizatriptan—HTR1F—central nervous system—attention deficit hyperactivity disorder	0.00223	0.0476	CbGeAlD
Rizatriptan—HTR1F—brain—attention deficit hyperactivity disorder	0.00177	0.0378	CbGeAlD
Rizatriptan—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00175	0.0373	CbGeAlD
Rizatriptan—HTR1D—forebrain—attention deficit hyperactivity disorder	0.0017	0.0361	CbGeAlD
Rizatriptan—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.00148	0.0316	CbGeAlD
Rizatriptan—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.00143	0.0305	CbGeAlD
Rizatriptan—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00141	0.0301	CbGeAlD
Rizatriptan—Zolmitriptan—MAOA—attention deficit hyperactivity disorder	0.0013	0.188	CrCbGaD
Rizatriptan—MAOA—forebrain—attention deficit hyperactivity disorder	0.00129	0.0275	CbGeAlD
Rizatriptan—Zolmitriptan—HTR1B—attention deficit hyperactivity disorder	0.00124	0.179	CrCbGaD
Rizatriptan—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00119	0.0255	CbGeAlD
Rizatriptan—HTR1B—midbrain—attention deficit hyperactivity disorder	0.00116	0.0246	CbGeAlD
Rizatriptan—HTR1D—midbrain—attention deficit hyperactivity disorder	0.00112	0.0239	CbGeAlD
Rizatriptan—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.00109	0.0233	CbGeAlD
Rizatriptan—Almotriptan—MAOA—attention deficit hyperactivity disorder	0.000984	0.142	CrCbGaD
Rizatriptan—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000951	0.0203	CbGeAlD
Rizatriptan—Sumatriptan—MAOA—attention deficit hyperactivity disorder	0.000948	0.137	CrCbGaD
Rizatriptan—Almotriptan—HTR1B—attention deficit hyperactivity disorder	0.00094	0.136	CrCbGaD
Rizatriptan—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000933	0.0199	CbGeAlD
Rizatriptan—HTR1D—nervous system—attention deficit hyperactivity disorder	0.00092	0.0196	CbGeAlD
Rizatriptan—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000915	0.0195	CbGeAlD
Rizatriptan—Sumatriptan—HTR1B—attention deficit hyperactivity disorder	0.000904	0.131	CrCbGaD
Rizatriptan—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000886	0.0189	CbGeAlD
Rizatriptan—MAOA—midbrain—attention deficit hyperactivity disorder	0.000853	0.0182	CbGeAlD
Rizatriptan—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000767	0.0163	CbGeAlD
Rizatriptan—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000739	0.0157	CbGeAlD
Rizatriptan—HTR1B—brain—attention deficit hyperactivity disorder	0.000727	0.0155	CbGeAlD
Rizatriptan—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000722	0.0154	CbGeAlD
Rizatriptan—HTR1D—brain—attention deficit hyperactivity disorder	0.000704	0.015	CbGeAlD
Rizatriptan—MAOA—nervous system—attention deficit hyperactivity disorder	0.000701	0.0149	CbGeAlD
Rizatriptan—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000675	0.0144	CbGeAlD
Rizatriptan—MAOA—cerebellum—attention deficit hyperactivity disorder	0.00066	0.0141	CbGeAlD
Rizatriptan—Sumatriptan—DRD2—attention deficit hyperactivity disorder	0.000608	0.0878	CrCbGaD
Rizatriptan—HTR1A—brain—attention deficit hyperactivity disorder	0.000586	0.0125	CbGeAlD
Rizatriptan—MAOA—brain—attention deficit hyperactivity disorder	0.000536	0.0114	CbGeAlD
Rizatriptan—HTR1F—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00015	0.00103	CbGpPWpGaD
Rizatriptan—MAOA—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00015	0.00103	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000149	0.00102	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000149	0.00102	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000148	0.00102	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000148	0.00102	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000147	0.00101	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000147	0.00101	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000146	0.000999	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000145	0.000996	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000144	0.00099	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000144	0.000987	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000144	0.000986	CbGpPWpGaD
Rizatriptan—MAOA—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000144	0.000986	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000143	0.000984	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000141	0.000969	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00014	0.000957	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000138	0.00095	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000138	0.000949	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000138	0.000945	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000137	0.000938	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000135	0.000926	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000135	0.000926	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000134	0.000919	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000134	0.000918	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000131	0.000899	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000131	0.000899	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000131	0.000895	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00013	0.000889	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000129	0.000883	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000128	0.000881	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.000874	CbGpPWpGaD
Rizatriptan—MAOA—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000127	0.000874	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000127	0.000871	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000127	0.000868	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000126	0.000863	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000126	0.000863	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000125	0.00086	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000125	0.00086	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000125	0.000856	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000123	0.000845	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000123	0.000843	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000123	0.000842	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000122	0.000834	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00012	0.00082	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000118	0.00081	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000117	0.000804	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000117	0.000799	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000116	0.000796	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000115	0.000787	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000115	0.000787	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000113	0.000774	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.000761	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000111	0.00076	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00011	0.000754	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00011	0.000752	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00011	0.000751	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000107	0.000737	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000107	0.000733	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000105	0.000723	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000104	0.000716	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000102	0.000701	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000102	0.000701	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000102	0.0007	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000102	0.000699	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000102	0.000699	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000101	0.00069	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0001	0.000687	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	9.98e-05	0.000685	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	9.98e-05	0.000684	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.9e-05	0.000679	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	9.87e-05	0.000677	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	9.78e-05	0.000671	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—COMT—attention deficit hyperactivity disorder	9.76e-05	0.000669	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.7e-05	0.000665	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	9.69e-05	0.000665	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.67e-05	0.000663	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	9.66e-05	0.000663	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.58e-05	0.000657	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.58e-05	0.000657	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9.5e-05	0.000652	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.5e-05	0.000652	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.48e-05	0.00065	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.38e-05	0.000644	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.38e-05	0.000644	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.38e-05	0.000644	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.35e-05	0.000642	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.28e-05	0.000637	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.28e-05	0.000637	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.09e-05	0.000624	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	9.06e-05	0.000621	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	9.01e-05	0.000618	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	8.93e-05	0.000612	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	8.8e-05	0.000603	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.75e-05	0.000601	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	8.74e-05	0.0006	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	8.74e-05	0.0006	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8.72e-05	0.000598	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.58e-05	0.000588	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.57e-05	0.000588	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.47e-05	0.000581	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.41e-05	0.000577	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.35e-05	0.000573	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.21e-05	0.000563	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	8.18e-05	0.000561	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.18e-05	0.000561	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.17e-05	0.000561	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.04e-05	0.000551	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.92e-05	0.000543	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.89e-05	0.000541	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.78e-05	0.000534	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.78e-05	0.000534	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.69e-05	0.000527	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.63e-05	0.000523	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.6e-05	0.000521	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.36e-05	0.000505	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.24e-05	0.000496	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.16e-05	0.000491	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.15e-05	0.00049	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.15e-05	0.00049	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.09e-05	0.000486	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.07e-05	0.000485	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.94e-05	0.000476	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.93e-05	0.000475	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	6.66e-05	0.000457	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.66e-05	0.000457	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	6.53e-05	0.000448	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	6.53e-05	0.000448	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.52e-05	0.000447	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.44e-05	0.000441	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.38e-05	0.000438	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.3e-05	0.000432	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.25e-05	0.000429	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.23e-05	0.000427	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.19e-05	0.000425	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.12e-05	0.00042	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.12e-05	0.00042	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.95e-05	0.000408	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.88e-05	0.000403	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.76e-05	0.000395	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.66e-05	0.000388	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.64e-05	0.000387	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.63e-05	0.000386	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.6e-05	0.000384	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.58e-05	0.000383	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.52e-05	0.000379	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.48e-05	0.000376	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.48e-05	0.000376	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.48e-05	0.000376	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.46e-05	0.000375	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.41e-05	0.000371	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.38e-05	0.000369	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.37e-05	0.000368	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.37e-05	0.000368	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.3e-05	0.000364	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.3e-05	0.000363	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.29e-05	0.000363	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.27e-05	0.000361	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.26e-05	0.000361	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.23e-05	0.000359	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.23e-05	0.000358	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.2e-05	0.000356	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.12e-05	0.000351	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.06e-05	0.000347	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.04e-05	0.000346	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.02e-05	0.000344	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.98e-05	0.000342	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.96e-05	0.00034	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.94e-05	0.000339	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.92e-05	0.000337	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.87e-05	0.000334	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.86e-05	0.000333	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.83e-05	0.000331	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.81e-05	0.00033	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.8e-05	0.000329	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.68e-05	0.000321	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.66e-05	0.00032	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.62e-05	0.000317	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.6e-05	0.000315	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.58e-05	0.000314	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.54e-05	0.000312	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.48e-05	0.000308	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.3e-05	0.000295	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.23e-05	0.00029	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.2e-05	0.000288	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.18e-05	0.000286	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.16e-05	0.000285	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.09e-05	0.000281	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.09e-05	0.000281	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	4.06e-05	0.000278	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.06e-05	0.000278	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.04e-05	0.000277	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.01e-05	0.000275	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	3.99e-05	0.000274	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.9e-05	0.000268	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.8e-05	0.000261	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.78e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.76e-05	0.000258	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.72e-05	0.000255	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.71e-05	0.000255	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.71e-05	0.000254	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.67e-05	0.000252	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.53e-05	0.000242	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.46e-05	0.000237	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.42e-05	0.000234	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.32e-05	0.000228	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.24e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.21e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.14e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.09e-05	0.000212	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.09e-05	0.000212	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.02e-05	0.000208	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.99e-05	0.000205	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.96e-05	0.000203	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.94e-05	0.000202	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.93e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.9e-05	0.000199	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.88e-05	0.000198	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.84e-05	0.000195	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.84e-05	0.000195	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.71e-05	0.000186	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.65e-05	0.000182	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.64e-05	0.000181	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.48e-05	0.00017	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	2.46e-05	0.000169	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.39e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.3e-05	0.000158	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.23e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.19e-05	0.00015	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.17e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.17e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.02e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.9e-05	0.00013	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.86e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.57e-05	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.5e-05	0.000103	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.5e-05	0.000103	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.47e-05	0.000101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.41e-05	9.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.37e-05	9.38e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.2e-05	8.2e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.14e-05	7.81e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	1.05e-05	7.23e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1e-05	6.89e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.83e-06	6.74e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.06e-06	6.22e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9e-06	6.17e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.73e-06	5.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.49e-06	5.14e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.89e-06	2.67e-05	CbGpPWpGaD
